Botanix Pharmaceuticals Limited (ASX:BOT)
Australia
· Delayed Price · Currency is AUD 0.0540
0.00 (0.00%)
Mar 10, 2026, 10:52 AM AEST
Botanix Pharmaceuticals Revenue
Botanix Pharmaceuticals had revenue of 16.51M AUD in the half year ending December 31, 2025, with 4,267.43% growth. This brings the company's revenue in the last twelve months to 21.92M, up 959.25% year-over-year. In the fiscal year ending June 30, 2025, Botanix Pharmaceuticals had annual revenue of 5.79M with 179.74% growth.
Revenue (ttm)
21.92M
Revenue Growth
+959.25%
P/S Ratio
5.46
Revenue / Employee
1.99M
Employees
11
Market Cap
119.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.79M | 3.72M | 179.74% |
| Jun 30, 2024 | 2.07M | -1.70M | -45.14% |
| Jun 30, 2023 | 3.77M | 1.02M | 36.94% |
| Jun 30, 2022 | 2.75M | -4.13M | -60.00% |
| Jun 30, 2021 | 6.89M | -686.66K | -9.07% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Island Pharmaceuticals | 62.85K |
| Recce Pharmaceuticals | 974.56K |
| Paradigm Biopharmaceuticals | 8.45K |
| Actinogen Medical | 7.36M |
| Starpharma Holdings | 14.58M |
| Arovella Therapeutics | 3.21M |
| LTR Pharma | 1.13M |
| Tetratherix | 2.00M |
Botanix Pharmaceuticals News
- 6 days ago - Botanix Pharmaceuticals Limited (BXPHF) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Botanix Pharmaceuticals Limited (BXPHF) Discusses Quarterly Activity, Cash Flow Update, and Progress of Sofdra for Hyperhidrosis Transcript - Seeking Alpha